Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats

European Journal of Pharmacology

Volumn 741, Issue , 2014, Pages 132-139

  Burke, Dennis A ^a   Heshmati, Pooneh ^b   Kholdebarin, Ehsan ^a   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Institute for Cognitive Science Studies   (Iran)

Author keywords

Antagonist; Dizocilpine; Learning; Nicotinic; 4 2; 7

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; DIHYDRO BETA ERYTHROIDINE; DIZOCILPINE MALEATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FEMALE; METABOLISM; PC12 CELL LINE; PHYSIOLOGY; RAT; SPATIAL LEARNING; SPRAGUE DAWLEY RAT;

ANIMALS; DIHYDRO-BETA-ERYTHROIDINE; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; NICOTINIC ANTAGONISTS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SPATIAL LEARNING;

EID: 84906964879     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.07.030     Document Type: Article

References (56)

1. N.A. Addy, A. Nakijama, and E.D. Levin Nicotinic mechanisms of memory: effects of acute local DHβE and MLA infusions in the basolateral amygdala Cogn. Brain Res. 16 2003 51 57
2. F.G. Boess, J. De Vry, C. Erb, T. Flessner, M. Hendrix, J. Luithle, C. Methfessel, B. Riedl, K. Schnizler, F.J. van der Staay, M. van Kampen, W.B. Wiese, and G. Koenig The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3 R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents J. Pharmacol. Exp. Ther. 321 2007 716 725
3. Brown, J.A., Wonnacott, S., 2014. Sazetidine-A activates and desensitizes native a7 nicotinic acetylcholine receptors. Neurochem. Res. in press 10.1007/s11064-11014-11302-11066.
4. J.J. Buccafusco, J.W. Brach, and A.V. Terry Desensitization of nicotinic acetylcholine receptors as a stategy for drug development J. Pharmacol. Exp. Ther. 328 2009 364 370
5. J.J. Buccafusco, W.J. Jackson, A.V. Terry, K.C. Marsh, M.W. Decker, and S.P. Arneric Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement Psychopharmacology 120 1995 256 266
6. B.J. Caldarone, D. Wang, N.E. Paterson, M. Manzano, A. Fedolak, K. Cavino, M. Kwan, T. Hanania, S.K. Chellappan, i.A.P. Kozikowsk, B. Olivier, M.R. Picciotto, and A. Ghavami Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380 Psychopharmacology 217 2011 199 210
7. R. Cannady, R. Weir, B. Wee, E. Gotschlich, N. Kolia, E. Lau, J. Brotherton, and E.D. Levin Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function Biochem. Pharmacol. 78 2009 788 794
8. W.K. Chan, P.T. Wong, and F.S. Sheu Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory Neuropharmacology 52 2007 1641 1649
9. J.W. Coe, P.R. Brooks, M.G. Vetelino, M.C. Wirtz, E.P. Arnold, J. Huang, S.B. Sands, T.I. Davis, L.A. Lebel, C.B. Fox, A. Shrikhande, J.H. Heym, E. Schaeffer, H. Rollema, Y. Lu, R.S. Mansbach, L.K. Chambers, C.C. Rovetti, D.W. Schulz, F.D. Tingley 3rd, and B.T. O'Neill Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation J. Med. Chem. 48 2005 3474 3477
10. L.P. Dwoskin, and P.A. Crroks Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery J. Pharmacol. Exp. Ther. 298 2001 395 402
11. R. Felix, and E.D. Levin Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats Neuroscience 81 1997 1009 1017
12. C. Fernandes, E. Hoyle, E. Dempster, L.C. Schalkwyk, and D.A. Collier Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory Genes, Brain Behav. 5 2006 433 440
13. C. Gotti, M. Moretti, I. Bohr, I. Ziabreva, S. Vailati, R. Longhi, L. Riganti, A. Gaimarri, I.G. McKeith, R.H. Perry, D. Aarsland, J.P. Larsen, E. Sher, R. Beattie, F. Clementi, and J.A. Court Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimers disease, Parkinsons disease and dementia with Lewy bodies by immunoprecipitation Neurobiol. Dis. 23 2006 481 489
14. B. Hahn, M. Shoaib, and I.P. Stolerman Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement Psychopharmacology (Berl) 217 2011 75 82
15. T.A. Hauser, A. Kucinski, K.G. Jordan, G.J. Gatto, S.R. Wersinger, R.A. Hesse, E.K. Stachowiak, M.K. Stachowiak, R.L. Papke, P.M. Lippiello, and M. Bencherif TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia Biochem. Pharmacol. 78 2009 803 812
16. E. Hoyle, R.F. Genn, C. Fernandes, and I.P. Stolerman Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task Psychopharmacology 189 2006 211 223
17. J.E. Johnson, S. Slade, C. Wells, A. Petro, H. Sexton, A.H. Rezvani, M.L. Brown, M.A. Paige, B.E. McDowell, Y. Xiao, K.J. Kellar, and E.D. Levin Chronic sazetidine-A infusion reduces nicotine self-administration in male and female rats Psychopharmacology 222 2012 269 276
18. M.S. Karadsheh, M.S. Shah, X. Tang, R.L. Macdonald, and J.A. Stitzel Functional characterization of mouse a4b2 nicotinic acetylcholine receptors stably expressed in HEK293T cells J. Neurochem. 91 2004 1138 1150
19. G. Keppel Design and Analysis: A Researchers Handbook 2nd ed. 1982 Prentice-Hall, Inc. Englewood Cliffs, New Jersey
20. S.C. Leiser, M.R. Bowlby, T.A. Comery, and J. Dunlop A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits Pharmacol. Ther. 122 2009 302 311
21. E.D. Levin Nicotinic receptor subtypes and cognitive function J. Neurobiol. 53 2002 633 640
22. E.D. Levin, C. Bettegowda, J. Blosser, and J. Gordon AR-R17779, an α7 nicotinic agonist, improves learning and memory in rats Behav. Pharmacol. 10 1999 675 680
23. E.D. Levin, C. Bettegowda, T. Weaver, and N.C. Christopher Nicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze Pharmacol. Biochem. Behav. 61 1998 335 340
24. E.D. Levin, A. Bradley, N. Addy, and N. Sigurani Hippocampal α7 and α4β2 nicotinic receptors and working memory Neuroscience 109 2002 757 765
25. E.D. Levin, S.J. Briggs, N.C. Christopher, and J.E. Rose Chronic nicotinic stimulation and blockade effects on working memory Behav. Pharmacol. 4 1993 179 182
26. E.D. Levin, and D.P. Caldwell Low-dose mecamylamine improves learning of rats in the radial-arm maze repeated acquisition procedure Neurobiol. Learn Mem. 86 2006 117 122
27. E.D. Levin, M. Castonguay, and G.D. Ellison Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats Behav. Neural. Biol. 48 1987 206 212
28. E.D. Levin, M. Cauley, and A.H. Rezvani Improvement of attentional function with antagonism of nicotinic receptors in female rats Eur. J.Pharmacol. 702 2013 269 274
29. E.D. Levin, and N.C. Christopher Persistence of nicotinic agonist RJR 2403 induced working memory improvement in rats Drug Dev. Res. 55 2002 97 103
30. E.D. Levin, F.J. McClernon, and A.H. Rezvani Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification and anatomic localization Psychopharmacology 184 2006 523 539
31. E.D. Levin, A. Petro, A.H. Rezvani, N. Pollard, N.C. Christopher, M. Strauss, J. Avery, J. Nicholson, and J.E. Rose Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice Behav. Brain Res. 196 2009 207 213
32. E.D. Levin, A.H. Rezvani, Y. Xiao, S. Slade, M. Cauley, D. Wells, D. Hampton, A. Petro, J.E. Rose, M.L. Brown, M.A. Paige, B.E. McDowell, and K. Kellar Sazetidine-A, a selective α4β2 nicotinic receptor desensitizing agent and partial agonist reduces nicotine self-administration in rats J. Pharmacol. Exp. Ther. 332 2010 933 939
33. M.J. Marks, P. Whiteaker, J. Calcaterra, J.A. Stitzel, A.E. Bullock, S.R. Grady, M.R. Picciotto, J.P. Changeux, and A.C. Collins Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta 2 subunit J. Pharmacol. Exp. Ther. 289 1999 1090 1103
34. A. Nott, and E.D. Levin Dorsal hippocampal α7 and α4β2 nicotinic receptors and memory Brain Res. 1081 2006 72 78
35. E.L.M. Ochoa, A. Chattopadhyay, and M.G. McNamee Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators Cell Mol. Neurobiol. 9 1989 141 178
36. R.L. Papke, L.P. Dwoskin, P.A. Crooks, G. Zheng, Z. Zhang, J.M. McIntosh, and C. Stokes Extending the analysis of nicotinic receptor antagonists with the study of alphs6 nicotinic receptor subunit chimeras Neuropharmacology 54 2008 1189 1200
37. M.R. Picciotto, N.A. Addy, Y.S. Mineur, and D.H. Brunzell It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood Prog. Neurobiol. 84 2008 329 342
38. P. Pichat, O.E. Bergis, J.P. Terranova, A. Urani, C. Duarte, V. Santucci, C. Gueudet, C. Voltz, R. Steinberg, J. Stemmelin, F. Oury-Donat, P. Avenet, G. Griebel, and B. Scatton SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia Neuropsychopharmacology 32 2007 17 34
39. R.C. Pitts, D.R. Buda, J.R. Keith, D.T. Cerutti, and M. Galizio Chlordiazepoxide and dizocilpine, but not morphine, selectively impair acquisition under a novel repeated-acquisition and performance task in rats Psychopharmacology (Berl) 189 2006 135 143
40. A. Pocivavsek, L. Icenogle, and E.D. Levin Hippocampal α7 and α4β2 nicotinic receptors and clozapine effects on memory Psychopharmacology 188 2006 596 604
41. A. Potter, J. Corwin, J. Lang, M. Piasecki, R. Lenox, and P.A. Newhouse Acute effects of the selective cholinergic channel activator (Nicotinic agonist) ABT-418 in Alzheimers disease Psychopharmacology 142 1999 334 342
42. A.S. Potter, K. Ryan, and P.A. Newhouse Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit/hyperactivity disorder (ADHD) Human Psychopharmacol.: Clin. Exp. 24 2009 309 317
43. J. Prickaerts, N.P. van Goethem, R. Chesworth, G. Shapiro, F.G. Boess, C. Methfessel, O.A. Reneerkens, D.G. Flood, D. Hilt, M. Gawryl, S. Bertrand, D. Bertrand, and G. Konig EVP-6124, a novel and selective alpha7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of alpha7 nicotinic acetylcholine receptors Neuropharmacology 62 2012 1099 1110
44. A.H. Rezvani, M. Cauley, H. Sexton, X. Xiao, M.L. Brown, M.A. Paige, B.E. McDowell, K.L. Kellar, and E.D. Levin Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent reverses dizocilpine and scopolamine-induced attentional impairments in rats Psychopharmacology 215 2011 621 630
45. A.H. Rezvani, M. Cauley, Y. Xiao, K.J. Kellar, and E.D. Levin Effects of chronic sazetidine-A, a selective β2∗ nicotinic receptor desensitizing agent on pharmacologically-induced impaired sustained attention in rats Psychopharmacology 22, 2012 69- 76.
46. A.H. Rezvani, S. Slade, C. Wells, A. Petro, T.K. Li, L. Lumeng, Y. Xiao, M.L. Brown, M.A. Paige, B.E. McDowell, K.J. Kellar, J.E. Rose, and E.D. Levin Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor desensitizing agent and partial agonist reduces both alcohol and nicotine self-administration in selectively-bred alcohol preferring (P) rats Psychopharmacology 211 2010 161 174
47. H. Rollema, M. Hajos, P.A. Seymour, R. Kozak, M.J. Majchrzak, V. Guanowsky, W.E. Horner, D.S. Chapin, W.E. Hoffmann, D.E. Johnson, S. McLean, J. Freeman, and K.E. Williams Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition Biochem. Pharmacol. 78 2009 813 824
48. A.V. Terry, J.J. Buccafusco, and M.A. Prendergast Dose-specific improvements in memory-related task performance by rats and aged monkeys administered the nicotinic-cholinergic antagonist mecamylamine Drug Dev. Res. 47 1999 127 136
49. K.R. Tietje, D.J. Anderson, R.S. Bitner, E.A. Blomme, P.J. Brackemeyer, C.A. Briggs, K.E. Browman, D. Bury, P. Curzon, K.U. Drescher, J.M. Frost, R.M. Fryer, G.B. Fox, J.H. Gronlien, M. Hakerud, E.J. Gubbins, S. Halm, R. Harris, R.J. Helfrich, K.L. Kohlhaas, D. Law, J. Malysz, K.C. Marsh, R.L. Martin, M.D. Meyer, A.L. Molesky, A.L. Nikkel, S. Otte, L. Pan, P.S. Puttfarcken, R.J. Radek, H.M. Robb, E. Spies, K. Thorin-Hagene, J.F. Waring, H. Ween, H. Xu, M. Gopalakrishnan, and W.H. Bunnelle Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties CNS Neurosci. Ther. 14 2008 65 82
50. F.J. van der Staay, K. Rutten, C. Erb, and A. Blokland Effects of the cognition impairer MK-801 on learning and memory in mice and rats Behav. Brain Res. 220 2011 215 229
51. M. Van Kampen, K. Selbach, R. Schneider, E. Schiegel, F. Boess, and R. Schreiber AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors Psychopharmacology 172 2004 375 383
52. T.L. Wallace, T.M. Ballard, B. Pouzet, W.J. Riedel, and J.G. Wettstein Drug targets for cognitive enhancement in neuropsychiatric disorders Pharmacol. Biochem. Behav. 99 2011 130 145
53. L. Ward, S.E. Mason, and W.C. Abraham Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats Pharmacol. Biochem. Behav. 35 1990 785 790
54. T.E. Wilens, J. Biederman, T.J. Spencer, J. Bostic, J. Prince, M.C. Monuteaux, J. Soriano, C. Fine, A. Abrams, M. Rater, and D. Polisner A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder Am. J. Psychiatry 156 1999 1931 1937
55. Y. Xiao, H. Fan, J.L. Musachio, Z.L. Wei, S.K. Chellappan, A.P. Kozikowski, and K.J. Kellar Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them Mol. Pharmacol. 70 2006 1454 1460
56. R. Zwart, A.L. Carbone, M. Moroni, I. Bermudez, A.J. Mogg, E.A. Folly, L.M. Broad, A.C. Williams, D. Zhang, C. Ding, B.A. Heinz, and E. Sher Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors Mol. Pharmacol. 73 2008 1838 1843